| PERIOD ENDING | 25-Sep-09 | 30-Jun-09 | 27-Mar-09 | 26-Dec-08 | | Total Revenue | 47,057 | 72,056 | 69,292 | 81,599 | | Cost of Revenue | 37,310 | 52,789 | 50,141 | 58,646 | | | Gross Profit | 9,747 | 19,267 | 19,151 | 22,953 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 12,778 | 12,627 | 14,517 | 17,008 | | Non Recurring |
-
| 1,188 |
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (3,031) | 5,452 | 4,634 | 5,945 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (60) | 784 | (1,049) | 192 | | Earnings Before Interest And Taxes | (3,091) | 6,236 | 3,585 | 6,137 | | Interest Expense | 619 | 650 | 526 | 714 | | Income Before Tax | (3,710) | 5,586 | 3,059 | 5,423 | | Income Tax Expense | (1,398) | 2,618 | 362 | 1,924 | | Minority Interest | (92) | (214) | 153 | (66) | | | | Net Income From Continuing Ops | (2,404) | 2,754 | 2,850 | 3,433 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,404) | 2,754 | 2,850 | 3,433 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,404) | $2,754 | $2,850 | $3,433 |
|
0.01% Nasdaq 
Income Statement
